文献速递乳腺泌尿生殖MR

新辅助全身治疗后多参数MRI结合临床病理特征评估临床淋巴结阳性乳腺癌腋窝病理完全缓解

Multiple-parameter MRI after neoadjuvant systemic therapy combining clinicopathologic features in evaluating axillary pathologic complete response in patients with clinically node-positive breast cancer.
PubMed 文献 · Br J Radiol · 2022-09-19

回顾性纳入2017年1月至2021年9月接受新辅助全身治疗并手术的临床淋巴结阳性乳腺癌女性,将MRI上腋窝淋巴结与病理匹配,分析MRI形态参数、TIC模式、ADC值及临床病理特征。多因素分析显示TIC模式、脂肪门、激素受体和HER2状态为腋窝pCR独立预测因子,联合模型AUC为0.85(95%CI:0.79,0.91)。

要点

  • 新辅助治疗后MRI腋窝淋巴结TIC模式、脂肪门及激素受体、HER2状态与腋窝pCR独立相关。
  • 联合MRI多参数与临床病理特征的模型评估腋窝pCR的AUC为0.85(95%CI:0.79,0.91)。
  • 腋窝淋巴结ADC值在pCR组与非pCR组间无显著差异(p=0.875)。

核心结论

  • 联合新辅助全身治疗后多参数MRI与临床病理特征可更准确识别新辅助全身治疗后达到腋窝病理完全缓解的乳腺癌患者。

研究设计与样本

  • 回顾性研究,纳入2017年1月至2021年9月接受新辅助全身治疗并手术的临床淋巴结阳性乳腺癌女性,病理确诊71例患者的137枚非pCR腋窝淋巴结和87例患者的87枚pCR腋窝淋巴结,MRI上所有腋窝淋巴结通过淋巴结标记或大小与病理匹配。

关键影像表现/征象

  • 腋窝淋巴结皮质厚度、脂肪门和TIC模式在pCR组与非pCR组间差异有统计学意义(均p<0.05)。
  • 腋窝淋巴结ADC值在两组间无显著差异(p=0.875)。

诊断标准与关键数值

  • 多因素分析中TIC模式为腋窝pCR独立预测因子(OR 2.67,95%CI:1.33,5.34,p=0.006)。
  • 多因素分析中脂肪门为腋窝pCR独立预测因子(OR 2.88,95%CI:1.39,5.98,p=0.004)。
  • 多因素分析中激素受体为腋窝pCR独立预测因子(OR 8.40,95%CI:2.48,28.38,p=0.001)。
  • 多因素分析中HER2状态为腋窝pCR独立预测因子(OR 8.57,95%CI:3.85,19.08,p<0.001)。
  • 联合上述预测因子的多因素模型AUC为0.85(95%CI:0.79,0.91)。

临床应用与阅片要点

  • 阅片时可关注新辅助全身治疗后腋窝淋巴结的皮质厚度、脂肪门及TIC模式,并结合激素受体和HER2状态综合评估腋窝pCR。
  • ADC值在本研究中未显示与腋窝pCR显著相关(p=0.875),解读时不宜单独依据ADC值判断腋窝pCR。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aimed to evaluate axillary pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) in clinically node-positive breast cancer (BC) patients based on post-NST multiple-parameter MRI and clinicopathological characteristics.

METHODS: In this retrospective study, females with clinically node-positive BC who received NST and followed by surgery between January 2017 and September 2021 were included. All axillary lymph nodes (ALNs) on MRI were matched with pathology by ALN markers or sizes. MRI morphological parameters, signal intensity curve (TIC) patterns and apparent diffusion coefficient (ADC) values of post-NST ALNs were measured. The clinicopathological characteristics was also collected and analyzed. Univariable and multivariable logistic regression analyses were performed to evaluate the independent predictors of axillary pCR.

RESULTS: Pathologically confirmed 137 non-pCR ALNs in 71 patients and 87 pCR ALNs in 87 patients were included in this study. Cortical thickness, fatty hilum, and TIC patterns of ALNs, hormone receptor, and human epidermal growth factor receptor 2 (HER2) status were significantly different between the two groups (all, p < 0.05). There was no significant difference for ADC values (p = 0.875). On multivariable analysis, TIC patterns (odds ratio [OR], 2.67, 95% confidence interval [CI]: 1.33, 5.34, p = 0.006), fatty hilum (OR, 2.88, 95% CI:1.39, 5.98, p = 0.004), hormone receptor (OR, 8.40, 95% CI: 2.48, 28.38, p = 0.001) and HER2 status (OR, 8.57, 95% CI: 3.85, 19.08, p < 0.001) were identified as independent predictors associated with axillary pCR. The area under the curve of the multivariate analysis using these predictors was 0.85 (95% CI: 0.79, 0.91).

CONCLUSION: Combining post-NST multiple-parameter MRI and clinicopathological characteristics allowed more accurate identification of BC patients who had received axillary pCR after NST.

ADVANCES IN KNOWLEDGE: A combined model incorporated multiple-parameter MRI and clinicopathologic features demonstrated good performance in evaluating axillary pCR preoperatively and non-invasively.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen M, Xu Z, Zhu C, et al. Multiple-parameter MRI after neoadjuvant systemic therapy combining clinicopathologic features in evaluating axillary pathologic complete response in patients with clinically node-positive breast cancer. Br J Radiol. 2022. PMID: 36000676. doi:10.1259/bjr.20220533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。